Fast 5-hour determination of angiotensin-converting enzyme genotypes from blood by SDS-PAGE using PhastSystem

Clinica Chimica Acta

Volumn 264, Issue 1, 1997, Pages 57-64

  Huang, Xiao Hong ^a   Koivula, Timo ^a   Ilveskoski, Erkki ^a,b   Karhunen, Pekka J ^a   Rantalaiho, Vappu ^a   Wirta, Ole ^a   Pasternack, Amos ^a   Lehtimäki, Terho ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

Angiotensin converting enzyme; Electrophoresis; Genetic polymorphism; Polymerase chain reaction

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TECHNIQUE;

AGED; ALLELES; DIABETES MELLITUS, TYPE 2; DNA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENOTYPE; HUMANS; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SENSITIVITY AND SPECIFICITY; SILVER STAINING; SODIUM DODECYL SULFATE; TIME FACTORS;

EID: 0030747498     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)00073-9     Document Type: Article

References (19)

1. Erdos E, Skigel RA. The angiotensin I-converting enzyme. Lab Invest 1987;56:345-8.
2. Hubert C, Houot AM, Vorvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene: two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 1991;266:15377-83.
3. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme level. J Clin Invest 1990;86:1343-6.
4. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
5. Gardemann A, Weiß T, Schwartz O, Eberbach A, Katz N, Hehrlein FW, Tillmanns H, Waas W, Haberbosch W. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation 1995;92:2796-9.
6. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K. Deletion polymorphism of the angiotensin 1-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-202.
7. Perola M, Sajantila A, Huttunen J, Sarti C, Stengr̄d J, Tamminen M, Tuomilehto J, Puska P, Peltonen L. Angiotensin-converting enzyme genotypes in the high and low risk area for coronary heart disease in Finland. Genet Epidemiol 1995;12:391-9.
8. Raynolds NW, Bristow MR, Bush EW, Abraham VYT, Lowes BD, Zisman LS, Taft CS, Perryman MB. Angiotensin-converting enzyme DD genotypes in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993;342:1073-5.
9. Marian AJ, Yu QT, Workman R, Gottfried G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993;342:1085-6.
10. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ. Left ventricular mass and function in relation to the insertion/deletion polymorphism of the angiotensin-converting enzyme gene in a population sample. Am J Physiol: Heart Circ Physiol 1994;267:1107-11.
11. Ukkola O, Savolainen MJ, Salmela PI, Dickhoff KV, Kiema T, Kesäniemi YA. Insertion/ deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus. J Mol Med 1995;73:307-11.
12. Kario K, Kanai N, Saito K, Nago N, Matsuo N, Shimada K. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 1996;93:1630-3.
13. Wirta O, Pasternack AI. Glomerular filtration rate and kidney size in type 2 non-insulin-dependent diabetes mellitus. Clin Nephrol 1990;44:1-7.
14. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCPI) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
15. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl 1993;3:120-1.
16. Fogarty DG, Maxwell AP, Doherty C, Hughes AE, Nevin NC. ACE gene typing. Lancet 1994;343:851.
17. PhastSystem Development Technique File No. 210.1986. Pharmacia, Uppsala, Sweden.
18. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
19. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994;43:690-5.